Showing results (1841-1850 of 39,482) with videos related to

Sort By:
Pageof 3,949
Blood|September 23, 2006
Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injuryJacob Sevastos, Sean E Kennedy, Darren R Davis, et al.
Blood|September 28, 2006
In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation toleranceDela Golshayan, Shuiping Jiang, Julia Tsang, et al.
Blood|September 28, 2006
STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90alpha and beta in multiple myeloma cells, which critically contribute to tumor-cell survivalManik Chatterjee, Sarika Jain, Thorsten Stühmer, et al.
Blood|September 28, 2006
ADAP is required for normal alphaIIbbeta3 activation by VWF/GP Ib-IX-V and other agonistsAna Kasirer-Friede, Barry Moran, Jennifer Nagrampa-Orje, et al.
Blood|September 28, 2006
The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genesCorinne Cayrol, Chrystelle Lacroix, Catherine Mathe, et al.
Blood|September 28, 2006
Early FDG-PET assessment in combination with clinical risk scores determines prognosis in recurring lymphomaBart W Schot, Josée M Zijlstra, Wim J Sluiter, et al.
Blood|October 5, 2006
Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-alpha/beta on antigen cross-presentationRandy S Longman, Deborah Braun, Sandra Pellegrini, et al.
Blood|October 5, 2006
Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosisNicolaus Kröger, Anita Badbaran, Ernst Holler, et al.
Blood|October 5, 2006
Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytesJan Ehrchen, Lars Steinmüller, Katarzyna Barczyk, et al.
Blood|December 1, 1990
Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation productsV W van Hinsbergh, K A Bauer, T Kooistra, et al.
Pageof 3,949